Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.

Colombia medica (Cali, Colombia) - 30 Sept 2015

Duque Andrés Felipe, Lopez Juan Carlos, Benitez Bruno, Hernandez Helena, Yunis Juan José, Fernandez William, Arboleda Humberto, Arboleda Gonzalo

Abstract excerpt

INTRODUCTION: Mutations in the leucine-rich repeat kinase 2 gene (LRRK2 or Dardarin) are considered to be a common cause of autosomal dominant and sporadic Parkinson´s disease, but the prevalence of these mutations varies among populations. OBJECTIVE: to analyzed the frequency of the LRRK2 p.G2019S mutation (c.6055 G>A transition) in a sample of Colombian patients. METHODS: In the present study we have analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Colombia

Share to Gene Frequency

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 26600626
PMCID: PMC4640433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.PMID 26600626Read ↗

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.Semantic proximity Read ↗

Parkinson's Disease: The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease geneticsSemantic proximity Read ↗

A study of LRRK2 mutations and Parkinson's disease in Brazil.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.Semantic proximity Read ↗

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Semantic proximity Read ↗

The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins.Semantic proximity Read ↗

LRRK2 mutations are a common cause of Parkinson's disease in Spain.Semantic proximity Read ↗

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.Semantic proximity Read ↗

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.Semantic proximity Read ↗

A common LRRK2 mutation in idiopathic Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.